Brief Cognitive Behavioral Therapy Via Telehealth Cuts Suicide Attempts
By Lori Solomon HealthDay Reporter
FRIDAY, Nov. 15, 2024 -- Brief cognitive behavioral therapy (BCBT) delivered via video telehealth is effective for reducing suicide attempts among adults with recent suicidal thoughts and/or behaviors, according to a study published online Nov. 12 in JAMA Network Open.
Justin C. Baker, Ph.D., from The Ohio State University in Columbus, and colleagues tested the efficacy of BCBT delivered via video telehealth for reducing suicide attempts and suicidal ideation among high-risk adults. Analysis included 96 adults randomly assigned to either BCBT or present-centered therapy (PCT).
The researchers found that from baseline to 12 months, 12 of 45 participants receiving PCT made 56 suicide attempts versus 11 of 51 participants receiving BCBT who made 36 suicide attempts. Significantly fewer suicide attempts were made among participants receiving BCBT versus PCT (mean, 0.70 attempts per participant versus 1.40 per participant), yielding a lower risk for suicide attempts (hazard ratio, 0.59). In both groups, severity of suicidal ideation significantly decreased, but there was no significant difference between the groups.
"To our knowledge, this study is the first study to demonstrate that individuals at high risk of suicide can be safely and effectively treated via telehealth, which has implications for increasing access to care, while maintaining treatment fidelity with established evidence-based treatments," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
People With Eating Disorders Report Success Self-Medicating With Non-Rx Drugs
FRIDAY, Aug. 1, 2025 -- People with eating disorders report success with self-medicating with nonprescribed drugs instead of prescription antidepressants, according to a study...
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 -- The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the...
Intranasal Administration of PET Radiotracer Delivers Insulin to Multiple Brain Regions
THURSDAY, July 31, 2025 -- Intranasal administration of [68Ga]Ga-NOTA-insulin is safe and delivers insulin to multiple brain regions, according to a study published online July 23...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.